Decreased binding of cytotoxic antibody by developing Schistosoma mansoni. Evidence for a surface change independent of host antigen adsorption and membrane turnover
- PMID: 325186
Decreased binding of cytotoxic antibody by developing Schistosoma mansoni. Evidence for a surface change independent of host antigen adsorption and membrane turnover
Abstract
Schistosoma mansoni schistosomula maintained in chemically defined culture media became increasingly resistant to the cytotoxic effects of infected guinea pig serum. Two- and 6-day-old schistosomula recovered from mice showed no uptake of IgG antibody from infected guinea pig serum, as revealed by the indirect fluorescent antibody test. Results from this test remained negative when the schistosomula were tested at 0 C, after exposure to drugs which inhibit synthetic and secretory processes, or after being killed by heat or formalin. In contrast, new schistosomula collected within 3 hr after skin penetration bound IgG from infection serum under all test conditions, and showed increased susceptibility to cytotoxicity after exposure to various drugs. It thus appears that soon after skin penetration schistosomula undergo surface changes which prevent binding of antibody from infection serum. These changes can apparently take place in the absence of host antigens, and once they have occurred, do not depend on worm physiological processes for their function.
Similar articles
-
Studies on the surface antigenicity and susceptibility to antibody-dependent killing of developing schistosomula using sera from chronically infected mice and mice vaccinated with irradiated cercariae.J Immunol. 1982 May;128(5):2101-6. J Immunol. 1982. PMID: 7061855
-
Inhibition of specific antibody binding to adult male Schistosoma mansoni by adsorbed host serum components.J Parasitol. 1985 Oct;71(5):530-4. J Parasitol. 1985. PMID: 4056998
-
The ability of fractionated sera from animals vaccinated with irradiated cercariae of Schistosoma mansoni to transfer immunity to mice.J Parasitol. 1989 Apr;75(2):252-60. J Parasitol. 1989. PMID: 2466975
-
Serobiological differentiation between antischistosomal (Schistosoma mansoni) antisera.Tropenmed Parasitol. 1981 Mar;32(1):43-7. Tropenmed Parasitol. 1981. PMID: 7015638
-
The modulation of expression of polypeptide surface antigens on developing schistosomula of Schistosoma mansoni.J Immunol. 1984 Nov;133(5):2725-30. J Immunol. 1984. PMID: 6481169
Cited by
-
Can antibody conjugated nanomicelles alter the prospect of antibody targeted therapy against schistosomiasis mansoni?PLoS Negl Trop Dis. 2023 Dec 1;17(12):e0011776. doi: 10.1371/journal.pntd.0011776. eCollection 2023 Dec. PLoS Negl Trop Dis. 2023. PMID: 38039267 Free PMC article.
-
Schistosomiasis: progress and problems.World J Gastroenterol. 2000 Feb;6(1):12-19. doi: 10.3748/wjg.v6.i1.12. World J Gastroenterol. 2000. PMID: 11819515 Free PMC article. No abstract available.
-
Schistosoma tegument proteins in vaccine and diagnosis development: an update.J Parasitol Res. 2012;2012:541268. doi: 10.1155/2012/541268. Epub 2012 Oct 18. J Parasitol Res. 2012. PMID: 23125917 Free PMC article.
-
Complement evasion by parasites: search for "Achilles' heel".Clin Exp Immunol. 1991 Oct;86 Suppl 1(Suppl 1):47-52. Clin Exp Immunol. 1991. PMID: 1934603 Free PMC article. Review. No abstract available.
-
Cercarial glycocalyx of Schistosoma mansoni activates human complement.Infect Immun. 1986 Jan;51(1):181-6. doi: 10.1128/iai.51.1.181-186.1986. Infect Immun. 1986. PMID: 3940995 Free PMC article.